HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II trial of piroxantrone in advanced non-small cell carcinoma of the lung. A Southwest Oncology Group study.

AuthorsS K Williamson, J J Crowley, R Livingston, A Hantel, J H Doroshow
JournalInvestigational new drugs (Invest New Drugs) Vol. 10 Issue 1 Pg. 29-30 (Apr 1992) ISSN: 0167-6997 [Print] United States
PMID1318871 (Publication Type: Clinical Trial, Journal Article, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Anthraquinones
  • Antineoplastic Agents
  • Pyrazoles
  • piroxantrone
Topics
  • Adult
  • Aged
  • Anthraquinones (administration & dosage, adverse effects)
  • Antineoplastic Agents (administration & dosage, adverse effects)
  • Carcinoma, Non-Small-Cell Lung (drug therapy)
  • Drug Evaluation
  • Female
  • Humans
  • Lung Neoplasms (drug therapy)
  • Male
  • Middle Aged
  • Pyrazoles (administration & dosage, adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: